Novo breathes life into Alzheimer's speculations after executive hunt
As the market awaits clarification on whether Novo Nordisk will move into the market for Alzheimer's treatments, the pharmaceutical firm embarks on a hunt for an executive position with this disease as one of its focus areas.
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN
Novo Nordisk now breathes life into the question of whether the Danish pharmaceutical firm is serious about officially starting the hunt for the gigantic market for pharmaceutical drugs against the dreaded brain disease Alzheimer's.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
